AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the target of a large decline in short interest in June. As of June 15th, there was short interest totaling 501,655 shares, a decline of 61.5% from the May 31st total of 1,303,551 shares. Based on an average daily trading volume, of 754,759 shares, the short-interest ratio is presently 0.7 days. Currently, 2.0% of the company’s stock are sold short.
Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund
A number of institutional investors have recently modified their holdings of the company. Crescent Grove Advisors LLC acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund in the 1st quarter valued at $6,614,000. Advisory Services Network LLC raised its holdings in AGF U.S. Market Neutral Anti-Beta Fund by 2,091.7% during the fourth quarter. Advisory Services Network LLC now owns 329,604 shares of the company’s stock worth $4,743,000 after buying an additional 314,565 shares during the last quarter. PMV Capital Advisers LLC lifted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 14.0% in the first quarter. PMV Capital Advisers LLC now owns 246,621 shares of the company’s stock valued at $3,443,000 after buying an additional 30,234 shares in the last quarter. Creative Financial Designs Inc. ADV lifted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2.5% in the third quarter. Creative Financial Designs Inc. ADV now owns 224,292 shares of the company’s stock valued at $3,571,000 after buying an additional 5,487 shares in the last quarter. Finally, Worth Asset Management LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the first quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock valued at $425,000 after buying an additional 5,190 shares during the last quarter.
AGF U.S. Market Neutral Anti-Beta Fund Stock Performance
BTAL stock opened at $11.37 on Friday. The stock’s 50 day simple moving average is $11.90 and its 200 day simple moving average is $13.31. The company has a market cap of $292.21 million, a P/E ratio of 17.67 and a beta of -0.63. AGF U.S. Market Neutral Anti-Beta Fund has a fifty-two week low of $10.86 and a fifty-two week high of $18.09.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Recommended Stories
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.
